Myelin-oligodendrocyte glycoprotein antibody-associated disease

R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Hope for patients with neuromyelitis optica spectrum disorders—from mechanisms to trials

SJ Pittock, A Zekeridou, BG Weinshenker - Nature Reviews Neurology, 2021 - nature.com
Neuromyelitis optica spectrum disorder (NMOSD) is a rare inflammatory CNS disease that
primarily manifests as relapsing episodes of severe optic neuritis and myelitis. Diagnosis of …

Interleukin-6 receptor blockade in treatment-refractory MOG-IgG–associated disease and neuromyelitis optica spectrum disorders

M Ringelstein, I Ayzenberg, G Lindenblatt… - Neurology …, 2021 - AAN Enterprises
Background and Objectives To evaluate the long-term safety and efficacy of tocilizumab
(TCZ), a humanized anti–interleukin-6 receptor antibody in myelin oligodendrocyte …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management

W Ambrosius, S Michalak, W Kozubski… - International journal of …, 2020 - mdpi.com
Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …

Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody–associated disease

JJ Chen, S Huda, Y Hacohen, M Levy, I Lotan… - JAMA …, 2022 - jamanetwork.com
Importance Recent studies suggest that maintenance intravenous immunoglobulin (IVIG)
may be an effective treatment to prevent relapses in myelin oligodendrocyte glycoprotein …

[HTML][HTML] EU paediatric MOG consortium consensus: Part 5–Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders

AL Bruijstens, EM Wendel, C Lechner, F Bartels… - European Journal of …, 2020 - Elsevier
In recent years, the understanding about the different clinical phenotypes, diagnostic and
prognostic factors of myelin oligodendrocyte glycoprotein-antibody-associated disorders …

Myelin oligodendrocyte glycoprotein-immunoglobulin G in the CSF: clinical implication of testing and association with disability

YN Kwon, B Kim, JS Kim, H Mo, K Choi… - Neurology …, 2021 - AAN Enterprises
Background and Objective To investigate the clinical relevance of CSF myelin
oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) testing in a large multicenter …

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic …

JJ Chen, ES Sotirchos, AD Henderson… - Multiple sclerosis and …, 2022 - Elsevier
Background Optic neuritis (ON) is the most common manifestation of myelin oligodendrocyte
glycoprotein antibody associated disorder (MOGAD) and multiple sclerosis (MS). Acute ON …

Myelitis and other autoimmune myelopathies

SL Chiriboga, EP Flanagan - CONTINUUM: Lifelong Learning in …, 2021 - journals.lww.com
PURPOSE OF REVIEW This article provides an update on the clinical diagnosis and
management of immune-mediated myelopathies, including the relevance of imaging …